Complex regulation of GH autofeedback under dual-peptide drive: Studies under a pharmacological GH and sex steroid clamp

American Journal of Physiology - Endocrinology and Metabolism

Volumn 300, Issue 6, 2011, Pages

  Veldhuis, Johannes D ^a   Erickson, Dana ^a   Miles, John M ^a   Bowers, Cyril Y ^b  

^a MAYO CLINIC   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Androgen; Estrogen; Growth hormone; Sex difference

Indexed keywords

ESTRADIOL; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PLACEBO; PRALMORELIN; SEX HORMONE; SODIUM CHLORIDE; TESTOSTERONE;

ADULT; AGED; ARTICLE; CLAMP; CONTROLLED STUDY; ENTROPY; FEMALE; GROWTH HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; MALE; NEGATIVE FEEDBACK; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; REGULATORY MECHANISM; SEX DIFFERENCE;

AGED; BODY MASS INDEX; DOUBLE-BLIND METHOD; ESTRADIOL; FEEDBACK, PHYSIOLOGICAL; FEMALE; GONADAL STEROID HORMONES; GONADOTROPIN-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LINEAR MODELS; MALE; MIDDLE AGED; OLIGOPEPTIDES; SEX CHARACTERISTICS; SEX HORMONE-BINDING GLOBULIN; TANDEM MASS SPECTROMETRY; TESTOSTERONE;

EID: 79957635124     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00054.2011     Document Type: Article

References (50)

1. Aguila MC, Boggaram V, McCann SM. Insulin-like growth factor-I modulates hypothalamic somatostatin through growth hormone releasingfactor increased somatostatin release and messenger ribonucleic acid levels. Brain Res 625: 213-218, 1993.
2. Anderson SM, Shah N, Evans WS, Patrie JT, Bowers CY, Veldhuis JD. Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women. J Clin Endocrinol Metab 86: 551-560, 2001.
3. Arvat E, Ceda GP, Di Vito L, Ramunni J, Gianotti L, Broglio F, Deghenghi R, Ghigo E. Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging. Pituitary 1: 51-58, 1998.
4. Barinaga M, Bilezikjian LM, Vale WW, Rosenfeld MG, Evans RM. Independent effects of growth hormone releasing factor on growth hormone release and gene transcription. Nature 314: 279-281, 1985.
5. Bowers CY. Synergistic release of growth hormone by GHRP and GHRH: scope and implication. In: Growth Hormone Secretagogues in Clinical Practice, edited by Bercu BB and Walker RF. New York: Marcel Dekker, 1998, p. 1-25.
6. Bowers CY, Granda R, Mohan S, Kuipers J, Baylink D, Veldhuis JD. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women. J Clin Endocrinol Metab 89: 2290-2300, 2004.
7. Carlsson LM, Clark RG, Robinson IC. Sex difference in growth hormone feedback in the rat. J Endocrinol 126: 27-35, 1990.
8. Chen JW, Højlund K, Beck-Nielsen H, Sandahl Christiansen J, Orskov H, Frystyk J. Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjects. J Clin Endocrinol Metab 90: 366-371, 2005.
9. Chihara K, Minamitani N, Kaji H, Arimura A, Fujita T. Intraventrically injected growth hormone stimulates somatostatin release into rat hypophyseal portal blood. Endocrinology 109: 2279-2281, 1981.
10. Clark RG, Carlsson LM, Rafferty B, Robinson IC. The rebound release of growth hormone (GH) following somatostatin infusion in rats involves hypothalamic GH-releasing factor release. J Endocrinol 119: 397-404, 1988.
11. Evans WS, Anderson SM, Hull LT, Azimi PP, Bowers CY, Veldhuis JD. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1,44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states. J Clin Endocrinol Metab 86: 700-712, 2001.
12. Fairhall KM, Mynett A, Robinson IC. Central effects of growth hormone- releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. J Endocrinol 144: 555-560, 1995.
13. Farhy LS, Veldhuis JD. Deterministic construct of amplifying actions of ghrelin on pulsatile GH secretion. Am J Physiol Regul Integr Comp Physiol 288: R1649-R1663, 2005.
14. Ferland L, Labrie F, Jobin M, Arimura A, Schally AV. Physiological role of somatostatin in the control of growth hormone and thyrotropin secretion. Biochem Biophys Res Commun 68: 149-156, 1976.
15. Fletcher TP, Thomas GB, Clarke IJ. Growth hormone-releasing and somatostatin concentrations in the hypophysial portal blood of conscious sheep during the infusion of growth hormone-releasing peptide-6. Domest Anim Endocrinol 13: 251-258, 1996.
16. Fukata J, Diamond DJ, Martin JB. Effects of rat growth hormone (rGH)-releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells. Endocrinology 117: 457-467, 1985.
17. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19: 717-797, 1998.
18. Guillaume V, Magnan E, Cataldi M, Dutour A, Sauze N, Renard M, Razafindraibe H, Conte-Devolx B, Deghenghi R, Lenaerts V. Growth hormone (GH)-releasing hormone secretion is stimulated by a new GHreleasing hexapeptide in sheep. Endocrinology 135: 1073-1076, 1994.
19. Hartman ML, Pincus SM, Johnson ML, Matthews DH, Faunt LM, Vance ML, Thorner MO, Veldhuis JD. Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release. J Clin Invest 94: 1277-1288, 1994.
20. Horvath S, Palkovits M, Gorcs T, Arimura A. Electron microscopic immunocytochemical evidence for the existence of bidirectional synaptic connections between growth hormone- and somatostatin-containing neurons in the hypothalamus of the rat. Brain Res 481: 8-15, 1989.
21. Hudson SB, Schroeder DR, Bailey JN, Mielke KL, Erickson D, Miles JM, Bowers CY, Veldhuis JD. Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp. J Clin Endocrinol Metab 95: 353-360, 2010.
22. Katakami H, Arimura A, Frohman LA. Growth hormone (GH)-releasing factor stimulates hypothalamic somatostatin release: an inhibitory feedback effect on GH secretion. Endocrinology 118: 1872-1877, 1986.
23. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660, 2000.
24. Kuehl RO. Split-plot designs. In: Statistical Principles of Research Design and Analysis. Belmont, CA: Duxbury, 1994, p. 473-498.
25. Low MJ, Otero-Corchon V, Parlow AF, Ramirez JL, Kumar U, Patel YC, Rubinstein M. Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth. J Clin Invest 107: 1571-1580, 2001.
26. Magnan E, Cataldi M, Guillaume V, Conte-Devolx B, Graziani N, Figaroli JC, Thomas F, Chihara K, Oliver C. Acute changes in growth hormone-releasing hormone secretion after injection of BIM 23014, a long acting somatostatin analog, in rams. Life Sci 51: 831-838, 1992.
27. Pantel J, Legendre M, Cabrol S, Hilal L, Hajaji Y, Morisset S, Nivot S, Vie-Luton MP, Grouselle D, de Kerdanet M, Kadiri A, Epelbaum J, Le Bouc Y, Amselem S. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest 116: 760-768, 2006.
28. Paulo RC, Brundage R, Cosma M, Mielke KL, Bowers CY, Veldhuis JD. Estrogen elevates the peak overnight production rate of acylated ghrelin. J Clin Endocrinol Metab 93: 4440-4447, 2008.
29. Pellegrini E, Bluet-Pajot MT, Mounier F, Bennett P, Kordon C, Epelbaum J. Central administration of a growth hormone (GH) receptor mRNA antisense increases GH pulsatility and decreases hypothalamic somatostatin expression in rats. J Neurosci 16: 8140-8148, 1996.
30. Pincus SM. Irregularity and asynchrony in biologic network signals. Methods Enzymol 321: 149-182, 2000.
31. Pincus SM, Hartman ML, Roelfsema F, Thorner MO, Veldhuis JD. Hormone pulsatility discrimination via coarse and short time sampling. Am J Physiol Endocrinol Metab 277: E948-E957, 1999.
32. Rigamonti AE, Cavallera G, Bonomo S, Deghenghi R, Locatelli V, Cella SG, Muller EE. Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: studies in dogs with the use of GHreleasing hormone and a GH-releasing peptide. Eur J Endocrinol 145: 635-644, 2001.
33. Robinson IC. The growth hormone secretory pattern: a response to neuroendocrine signals. Acta Paediatr Scand Suppl 372: 70-78, 1991.
34. Roelfsema F, Biermasz NR, Veldman RG, Veldhuis JD, Frolich M, Stokvis-Brantsma WH, Wit JM. Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab 86: 2459-2464, 2001.
35. Sato M, Frohman LA. Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats. Endocrinology 133: 793-799, 1993.
36. Shuto Y, Shibasaki T, Otagiri A, Kuriyama H, Ohata H, Tamura H, Kamegai J, Sugihara H, Oikawa S, Wakabayashi I. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 109: 1429-1436, 2002.
37. Takahashi PY, Votruba P, Abu-Rub M, Mielke K, Veldhuis JD. Age attenuates testosterone secretion driven by amplitude-varying pulses of recombinant human luteinizing hormone during acute gonadotrope inhibition in healthy men. J Clin Endocrinol Metab 92: 3626-3632, 2007.
38. Tannenbaum GS, Epelbaum J, Bowers CY. Interrelationship between the novel peptide ghrelin, somatostatin and growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion. Endocrinology 144: 967-974, 2003.
39. Veldhuis JD, Anderson SM, Iranmanesh A, Bowers CY. Testosterone blunts feedback inhibition of GH secretion by experimentally elevated IGF-I concentrations. J Clin Endocrinol Metab 90: 1613-1617, 2005.
40. Veldhuis JD, Evans WS, Bowers CY. Impact of estradiol supplementation on dual peptidyl drive of growth-hormone secretion in postmenopausal women. J Clin Endocrinol Metab 87: 859-866, 2002.
41. Veldhuis JD, Evans WS, Bowers CY. Estradiol supplementation enhances submaximal feedforward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu. J Clin Endocrinol Metab 88: 5484-5489, 2003.
42. Veldhuis JD, Frystyk J, Iranmanesh A, Orskov H. Testosterone and estradiol regulate free IGF-I, IGFBP-I and dimeric IGF-I/IGFBP-I concentrations. J Clin Endocrinol Metab 90: 2941-2947, 2005.
43. Veldhuis JD, Keenan DM, Iranmanesh A, Mielke K, Miles JM, Bowers CY. Estradiol potentiates ghrelin-stimulated pulsatile GH secretion in postmenopausal women. J Clin Endocrinol Metab 91: 3559-3565, 2006.
44. Veldhuis JD, Metzger DL, Martha PM Jr, Mauras N, Kerrigan JR, Keenan B, Rogol AD, Pincus SM. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamosomatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 82: 3414-3420, 1997.
45. Veldhuis JD, Mielke KL, Cosma M, Soares-Welch C, Paulo R, Miles JM, Bowers CY. Aromatase and 5-alpha-reductase inhibition during an exogenous testosterone clamp unveils selective sex-steroid modulation of somatostatin and growth-hormone secretagogue actions in healthy older men. J Clin Endocrinol Metab 94: 973-981, 2009.
46. Veldhuis JD, Roemmich JN, Richmond EJ, Bowers CY. Somatotropic and gonadotropic axes linkages in infancy, childhood, and the pubertyadult transition. Endocr Rev 27: 101-140, 2006.
47. Veldhuis JD, Roemmich JN, Rogol AD. Gender and sexual maturationdependent contrasts in the neuroregulation of growth hormone secretion in prepubertal and late adolescent males and females-a general clinical research center-based study. J Clin Endocrinol Metab 85: 2385-2394, 2000.
48. Veldhuis JD, Straume M, Iranmanesh A, Mulligan T, Jaffe CA, Barkan A, Johnson ML, Pincus SM. Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans. Am J Physiol Regul Integr Comp Physiol 280: R721-R729, 2001.
49. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335: 1363-1367, 1996.
50. Zar JH. Biostatistical Analysis. Upper Saddle River, NJ: Prentice Hall, 1996.